Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-04

Clinical Trial Update: Study Evaluating On-Demand Treatment With BeneFIX In Chinese Subjects [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating on-demand BeneFIX for Hemophilia B in Chinese subjects has completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BeneFIX (recombinant coagulation factor IX concentrate)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Hemophilia B | Phase 3 | Status: COMPLETED | Results posted: 2011-01-04